Chronic disease management platform Hello Heart will now integrate with LifeScan OneTouch meters as part of its program for diabetes management.
The Redwood City, California-based company started out in hypertension, but has been expanding into diabetes for the past year. OneTouch meters, formerly owned by Johnson & Johnson, are the first of a handful of glucometer brands the company intends...
AgaMatrix, the medical device that launched the first ever iPhone-connected glucometer, has secured a $32 million loan in order to reorganize the company into two distinct entities: AgaMatrix, which will continue to focus on Bluetooth-enabled glucometer's such as the company's newest Jazz Wireless 2 device, and WaveForm Technologies, which will be focused on the development of a proprietary...
Mountain View, California-based Livongo Health, the chronic condition management technology company founded by former Allscripts CEO Glen Tullman, has acquired Diabeto, a diabetes management company based in Piscataway, New Jersey in the US and Maharashtra in India. The terms of the acquisition were not disclosed.
Though it was founded in 2012, Diabeto really hit the scene in 2015 with an...
Minnesota-based Pops! Diabetes Care, which is working on a digital device and diabetes management platform, has raised a little over $1.2 million to bring its product to market. MedCity News confirmed the funding with Pops! CEO and cofounder Lonny Stormo, who previously served in executive roles at Medtronic. Last year, the company raised $500,000 from Minneapolis accelerator TreeHouse Health....
New York City and Austin, Texas-based Informed Data Systems has raised $8 million for its One Drop mobile diabetes management platform. The round was led by RRE, with additional contributions from BoxGroup, Capital Factory, and existing investors LAUNCH fund and Neu Ventures.
One Drop is a direct-to-consumer app for diabetes management, currently available on iOS and Apple Watch. It allows users...
Glen Tullman, the former Allscripts CEO who left the company at the end of 2012 by mutual agreement, is back in the health field. His newest venture, Livongo, launched from the stage of TechCrunch's Disrupt conference in San Francisco and has already raised a $10 million funding round from General Catalyst Partners.
"Our plan is to use the experience gained in Silicon Valley on consumer ...
New York City-based medical device maker Philosys received FDA 510(k) clearance this week for its smartphone-connected glucose meter, Gmate Smart.
To use the Gmate Smart glucometer, users launch the device's connected app, plug in their Gmate glucometer through the audio jack, insert a test strip into the glucometer, add a blood sample, and view results on the app. Gmate Smart's app is only...
iHealth Labs, a San Francisco-based subsidiary of China's Andon Health, has received FDA clearance for iHealth Align, a new smaller, smartphone-enabled glucometer. iHealth announced the product along with a new pricing strategy for diabetes care, dubbed Simple Savings.
The new device is just slightly larger than a quarter in circumference and plugs into the phone's headphone jack, allowing it to...
Diabetes tracking company Glooko, which offers a cloud-based logbook app and a cable that connects the iPhone to commercially available blood glucose monitors, has launched -- and received FDA 510(k) clearance for -- a new app and cable for Android phones.
Glooko's new app will connect to the same cloud-based web dashboard as the company's iPhone app. That platform was FDA cleared in May and...
